Pneumoconioses (Silicosis, Asbestosis, Coal Worker's, Berylliosis)
Occupational interstitial lung diseases from inhaled inorganic dusts.
Also known as: silicosis, asbestosis, coal worker's pneumoconiosis, CWP, black lung, berylliosis, pneumoconiosis
Overview
Group of interstitial lung diseases caused by chronic inhalation of inorganic mineral dusts in occupational settings. Major forms: silicosis (silica), asbestosis (asbestos fibers), coal worker's pneumoconiosis (coal dust), and chronic beryllium disease (beryllium — granulomatous, sarcoid-like).
Epidemiology
Resurgence of accelerated silicosis among young engineered stone (quartz) countertop workers in US/Australia. Asbestosis declining due to bans but legacy exposures persist. CWP persists in coal mining regions globally. Berylliosis in aerospace, electronics, ceramics workers.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Pneumoconioses (Silicosis, Asbestosis, Coal Worker's, Berylliosis) outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Silicosis: mining, quarrying, sandblasting, foundry work, engineered stone (quartz) countertop fabrication, ceramics, glass manufacture
- Asbestosis: shipbuilding, construction (insulation, roofing), automotive brake/clutch work, asbestos mining (legacy exposures dominate)
- Coal worker's pneumoconiosis: underground coal mining (cumulative exposure)
- Berylliosis: aerospace, nuclear, electronics, ceramic and dental laboratory work
- Cumulative exposure duration and intensity drive risk; smoking synergistic for malignancy
Pathophysiology
Inhaled mineral particles reach alveoli; alveolar macrophages phagocytose but cannot digest them → chronic inflammation, fibrogenic cytokine release (TGF-beta, TNF-alpha), fibroblast proliferation, collagen deposition. Silica is the most cytotoxic and fibrogenic. Asbestos fibers (amphiboles especially) cause pleural plaques, fibrosis, and malignancy. Beryllium triggers a delayed-type hypersensitivity (CD4 T-cell) granulomatous response indistinguishable histologically from sarcoidosis.
Clinical presentation
Symptoms
- Progressive exertional dyspnea (most common across all forms)
- Cough — often non-productive; productive with chronic bronchitis in CWP
- Chest discomfort
- Constitutional symptoms in advanced disease
- Asbestos: long latency (20-40 years from first exposure)
- Acute silicosis: rapidly progressive dyspnea after heavy short-term exposure (engineered stone, sandblasting)
Signs / physical exam
- Bibasilar Velcro crackles (asbestosis, advanced silicosis)
- Clubbing (asbestosis > silicosis)
- Findings of cor pulmonale in advanced disease
- Pleural plaques on imaging suggest asbestos exposure
Classic findings
Silicosis: upper-lobe nodules with hilar 'eggshell' calcifications. Asbestosis: lower-lobe fibrosis + pleural plaques (often calcified). CWP: small upper-lobe rounded opacities, may progress to progressive massive fibrosis. Berylliosis: indistinguishable from sarcoidosis.
Differential diagnosis
- Idiopathic pulmonary fibrosis — No occupational exposure history; UIP pattern; older male smokers
- Sarcoidosis — Granulomatous disease without beryllium exposure; mediastinal lymphadenopathy; non-caseating granulomas
- Tuberculosis — Silicosis predisposes — silicotuberculosis; always exclude with sputum AFB/IGRA
- Hypersensitivity pneumonitis — Organic dust exposure (birds, mold), upper-lobe centrilobular nodules, lymphocytic BAL
- Connective tissue disease-ILD — Autoimmune features; positive serologies (ANA, RF, anti-CCP)
- Lung cancer / mesothelioma (asbestos) — Mass lesion, pleural thickening with rind; biopsy diagnostic
Diagnostic workup
Labs
- Detailed occupational history is essential
- Beryllium lymphocyte proliferation test (BeLPT) — definitive for chronic beryllium disease
- QuantiFERON / PPD in silicosis (increased TB risk — silicotuberculosis)
- Sarcoid workup if granulomatous: ACE, calcium, exclude alternatives
Imaging
- CXR: simple silicosis — upper-lobe small (<10 mm) rounded opacities; complicated silicosis — progressive massive fibrosis (>10 mm conglomerate masses); eggshell calcification of hilar nodes
- Asbestosis: lower-lobe reticular/honeycomb fibrosis + pleural plaques (often calcified diaphragmatic), shaggy heart border
- CWP: small rounded opacities upper lobes, similar to silicosis but without eggshell calcifications
- HRCT: characterize fibrosis distribution, nodule pattern, pleural disease, exclude malignancy
- PFTs: restrictive pattern with reduced DLCO; obstructive component in CWP with chronic bronchitis
Other studies
- Bronchoscopy with biopsy if diagnosis uncertain or malignancy suspected
- BeLPT (blood or BAL) for chronic beryllium disease
- Lung biopsy rarely needed when occupational exposure + classic imaging are present
Diagnostic algorithm
| Pneumoconiosis | Exposure | CXR Pattern | Distinctive Features |
|---|---|---|---|
| Silicosis | Quartz dust (mining, sandblasting, engineered stone) | Upper-lobe small nodules; eggshell hilar node calcification; PMF | TB risk; autoimmune associations; accelerated form in engineered stone workers |
| Asbestosis | Asbestos fibers (construction, shipbuilding) | Lower-lobe reticular fibrosis; pleural plaques | Long latency (20-40 yr); risk of mesothelioma and lung cancer (synergy with smoking) |
| Coal Worker's Pneumoconiosis | Coal dust (mining) | Upper-lobe small rounded opacities; PMF in complicated disease | Black lung; Caplan syndrome with RA |
| Chronic Beryllium Disease | Beryllium dust (aerospace, electronics, ceramics) | Mimics sarcoidosis — hilar adenopathy + granulomas | BeLPT diagnostic; treat with steroids like sarcoid |
Treatment
First-line
- No specific cure for any pneumoconiosis — supportive care is the mainstay
- Remove from further exposure (legally protected occupational right)
- Smoking cessation — especially critical in asbestos exposure (synergistic lung cancer risk; ~50× in smokers with asbestos vs ~5× alone)
- Vaccinations: annual influenza, pneumococcal, COVID-19, RSV (age ≥60), Tdap
- Pulmonary rehabilitation, supplemental oxygen for hypoxemia
- Treat comorbid airflow obstruction (bronchodilators, ICS) in CWP
- Annual TB screening (IGRA) in silicosis; treat LTBI; consider 4-drug therapy if active
- Chronic beryllium disease — corticosteroids (prednisone 20-40 mg/day) for symptomatic disease, similar to sarcoidosis
Second-line / adjunct
- Lung transplantation for end-stage disease in select patients
- Surveillance for malignancy in asbestos-exposed: low-dose CT screening, especially with concomitant smoking; awareness for mesothelioma (insidious chest pain, pleural effusion, pleural thickening)
- Whole-lung lavage for severe acute silicosis (anecdotal, specialized centers)
- Antifibrotic therapy (pirfenidone, nintedanib) — emerging role for progressive pulmonary fibrosis phenotype, including occupational ILDs (PF-ILD)
- Workers' compensation and occupational disease reporting
Complications
- Progressive massive fibrosis (silicosis, CWP)
- Tuberculosis and atypical mycobacterial infection (especially silicosis)
- Lung cancer (all pneumoconioses, multiplied by smoking)
- Mesothelioma (asbestos — even brief exposure; latency 20-40 years)
- Pulmonary hypertension, cor pulmonale, respiratory failure
- Caplan syndrome (rheumatoid pneumoconiosis with large necrotic nodules)
- Autoimmune disease (silicosis — increased scleroderma, RA, SLE)
PANCE pearls
- Engineered stone (quartz) countertops have caused a global epidemic of accelerated silicosis in young workers — high silica content + dry cutting.
- Eggshell calcification of hilar lymph nodes is the classic silicosis finding.
- Pleural plaques (often calcified diaphragmatic) are pathognomonic for asbestos exposure but do not require asbestosis; mesothelioma can occur without asbestosis.
- Silicosis dramatically increases TB risk — screen annually with IGRA; consider isoniazid prophylaxis even with intermediate risk.
- Chronic beryllium disease mimics sarcoidosis histologically — BeLPT testing distinguishes; ask about aerospace, electronics, ceramic dust exposure.
References
- ATS 2010 — ATS Statement on Occupational Contribution to the Burden of Airway Disease (Am J Respir Crit Care Med 2003)
- MMWR 2019 — Severe Silicosis in Engineered Stone Fabrication Workers — California, Colorado, Texas, and Washington, 2017-2019 (Rose et al., MMWR 2019)
- Helsinki Criteria 2014 — Asbestos, Asbestosis, and Cancer — Helsinki Criteria for Diagnosis and Attribution 2014 (Wolff et al., Scand J Work Environ Health 2016)
- ATS 2014 — Chronic Beryllium Disease — ATS Official Statement (Balmes et al., Am J Respir Crit Care Med 2014)
Practice Pulmonary questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.